NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

8-K - BeOne Medicines Ltd. - 2.02 / 9.01

Filed: 2026-04-14 AccNo: 0001651308-26-000008 Size: 202 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
发布时间04/14 13:49 UTC
首次发现04/14 13:52 UTC
热度106.5
重要度76
情绪+0.04

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 787 字符

Form 8-K - Current report: SEC Accession No. 0001651308-26-000008

Filing Date: 2026-04-14

Accepted: 2026-04-14 09:49:37

Documents: 12

Period of Report: 2026-04-14

Items: Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

BeOne Medicines Ltd. (Filer) CIK : 0001651308 (see all company filings) EIN. : 981209416 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 26859439 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | bgne-20260414.htm iXBRL | 8-K

2 | EX-99.1 | a20260414formxfy2025staran.htm | EX-99.1

3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bgne-20260414.xsd | EX-101.SCH

4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bgne-20260414_lab.xml | EX-101.LAB